Yongjun Cha

941 total citations
39 papers, 562 citations indexed

About

Yongjun Cha is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Yongjun Cha has authored 39 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Yongjun Cha's work include Colorectal Cancer Treatments and Studies (14 papers), Cancer Treatment and Pharmacology (8 papers) and Genetic factors in colorectal cancer (7 papers). Yongjun Cha is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Cancer Treatment and Pharmacology (8 papers) and Genetic factors in colorectal cancer (7 papers). Yongjun Cha collaborates with scholars based in South Korea, United States and Ethiopia. Yongjun Cha's co-authors include Sae‐Won Han, Do‐Youn Oh, Seock‐Ah Im, Yung‐Jue Bang, Tae‐You Kim, Kyung-Hun Lee, Moon Ki Choi, Gyeong Hoon Kang, Seung‐Yong Jeong and Ho Jin Kim and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Yongjun Cha

36 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongjun Cha South Korea 15 340 168 157 119 105 39 562
Rie Yasuoka Japan 11 248 0.7× 309 1.8× 112 0.7× 112 0.9× 163 1.6× 32 660
Kimihiro Tanaka Japan 12 211 0.6× 228 1.4× 106 0.7× 57 0.5× 61 0.6× 51 530
Cristiana Ercolani Italy 14 204 0.6× 312 1.9× 110 0.7× 41 0.3× 88 0.8× 32 657
Yoshiki Mizukami Japan 9 468 1.4× 188 1.1× 89 0.6× 41 0.3× 101 1.0× 14 784
A M Gröger United States 6 383 1.1× 273 1.6× 99 0.6× 47 0.4× 56 0.5× 10 511
Saif Zaman United States 13 351 1.0× 175 1.0× 47 0.3× 37 0.3× 39 0.4× 38 518
Tzu‐Ju Chen Taiwan 14 163 0.5× 342 2.0× 130 0.8× 55 0.5× 98 0.9× 51 591
Tamako Konkin United States 7 233 0.7× 319 1.9× 123 0.8× 66 0.6× 126 1.2× 8 762
Yuko Hosoe Japan 13 853 2.5× 326 1.9× 198 1.3× 93 0.8× 61 0.6× 21 1.3k
Ruochen Li China 18 575 1.7× 313 1.9× 254 1.6× 64 0.5× 119 1.1× 42 1.0k

Countries citing papers authored by Yongjun Cha

Since Specialization
Citations

This map shows the geographic impact of Yongjun Cha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjun Cha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjun Cha more than expected).

Fields of papers citing papers by Yongjun Cha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongjun Cha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjun Cha. The network helps show where Yongjun Cha may publish in the future.

Co-authorship network of co-authors of Yongjun Cha

This figure shows the co-authorship network connecting the top 25 collaborators of Yongjun Cha. A scholar is included among the top collaborators of Yongjun Cha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongjun Cha. Yongjun Cha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wainberg, Zev A., Yongjun Cha, Jasmaninder Singh Grewal, et al.. (2024). 659P Combination treatment with TTX-030, a first-in-class anti-CD39 antibody, in patients with advanced pancreatic cancer. Annals of Oncology. 35. S519–S520. 3 indexed citations
2.
O’Kane, Grainne M., Do‐Youn Oh, Jennifer L. Spratlin, et al.. (2024). A phase 2 study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pretreated advanced biliary tract cancer: Efficacy and safety analysis (BOLD-100-001).. Journal of Clinical Oncology. 42(16_suppl). 4115–4115. 2 indexed citations
3.
4.
Cha, Yongjun, Sheehyun Kim, & Sae‐Won Han. (2023). Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers. Cancer Research and Treatment. 55(2). 367–384. 6 indexed citations
5.
Kim, Sheehyun, Yongjun Cha, Yoojoo Lim, et al.. (2023). Mutational evolution after chemotherapy‐progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis. International Journal of Cancer. 153(3). 571–583. 6 indexed citations
6.
Lee, Keun‐Wook, Sae‐Won Han, Tae Won Kim, et al.. (2023). A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer. Cancer Research and Treatment. 56(2). 590–601. 1 indexed citations
7.
8.
Hoang, Tung, Dae Kyung Sohn, Byung Chang Kim, Yongjun Cha, & Jeongseon Kim. (2022). Efficacy and Safety of Systemic Treatments Among Colorectal Cancer Patients: A Network Meta-Analysis of Randomized Controlled Trials. Frontiers in Oncology. 11. 756214–756214. 9 indexed citations
9.
Choi, Moon Ki, Yongjun Cha, & Ji Yeon Baek. (2021). Retreatment of Irinotecan in Later Lines of Therapy for Metastatic Colorectal Cancer: A Retrospective Study. Oncology. 99(10). 665–672. 1 indexed citations
10.
Kim, Su‐Hyun, Moon Ki Choi, Na-Young Park, et al.. (2020). Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy. Scientific Reports. 10(1). 7995–7995. 68 indexed citations
11.
Lee, Dae-Won, Sae‐Won Han, Yongjun Cha, et al.. (2019). Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy. BMC Cancer. 19(1). 421–421. 3 indexed citations
12.
Cha, Yongjun, Sun Young Kim, Hyun Yang Yeo, et al.. (2018). Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer. Neoplasia. 21(1). 146–155. 13 indexed citations
13.
Lee, Sung Uk, Dae Yong Kim, Tae Hyun Kim, et al.. (2018). Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer. International Journal of Clinical Oncology. 23(5). 924–929. 2 indexed citations
14.
Bae, Jeong Mo, Jung Ho Kim, Yoonjin Kwak, et al.. (2017). Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system. British Journal of Cancer. 116(8). 1012–1020. 38 indexed citations
15.
Cha, Yongjun, Kyung-Ju Kim, Sae‐Won Han, et al.. (2016). Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer. British Journal of Cancer. 115(2). 164–171. 37 indexed citations
16.
Song, Sang-Hyun, Jiyeon Yun, Yongjun Cha, et al.. (2015). Identification of Long-Range Epigenetic Silencing on Chromosome 15q25 and Its Clinical Implication in Gastric Cancer. American Journal Of Pathology. 185(3). 666–678. 5 indexed citations
17.
Lee, Dae‐Won, Sae‐Won Han, Yongjun Cha, et al.. (2015). Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX. Clinical Epigenetics. 7(1). 63–63. 17 indexed citations
18.
Lee, Dae‐Won, Sae‐Won Han, Yongjun Cha, et al.. (2015). Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients. BMC Cancer. 15(1). 690–690. 9 indexed citations
19.
Cha, Yongjun, Sae‐Won Han, Hyesil Seol, et al.. (2014). Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancer.. PubMed. 34(8). 4275–80. 8 indexed citations
20.
Kim, Seok Jin, Hyo Jin Lee, Hawk Kim, et al.. (2007). Varicella Zoster Virus Reactivation with the Use of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients.. Blood. 110(11). 4843–4843.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rie Yasuoka Breakdown of academic impact, for papers by Kimihiro Tanaka Breakdown of academic impact, for papers by Cristiana Ercolani Breakdown of academic impact, for papers by Yoshiki Mizukami Breakdown of academic impact, for papers by A M Gröger Breakdown of academic impact, for papers by Saif Zaman Breakdown of academic impact, for papers by Tzu‐Ju Chen Breakdown of academic impact, for papers by Tamako Konkin Breakdown of academic impact, for papers by Yuko Hosoe Breakdown of academic impact, for papers by Ruochen Li
Rankless by CCL
2026